This Article Full Text Full Text (PDF) All Versions of this Article: 27/2/141    most recent Final Manuscript Author Manuscript Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murphy, V. E. Articles by Clifton, V. L. Search for Related Content PubMed PubMed Citation Articles by Murphy, V. E. Articles by Clifton, V. L.

Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus

Mothers and Babies Research Centre (V.E.M., R.S., W.B.G., V.L.C.) and Department of Respiratory and Sleep Medicine (V.E.M.), Hunter Medical Research Institute, University of Newcastle, New South Wales 2310, Australia

Correspondence: Address all correspondence and requests for reprints to: Dr. Vicki Clifton, Mothers and Babies Research Centre, Endocrine Unit, John Hunter Hospital, Locked Bag 1, Hunter Region Mail Centre, Newcastle, New South Wales, 2310, Australia. E-mail: vicki.clifton{at}newcastle.edu.au

The environment in which the fetus develops is critical for its survival and long-term health. The regulation of normal human fetal growth involves many multidirectional interactions between the mother, placenta, and fetus. The mother supplies nutrients and oxygen to the fetus via the placenta. The fetus influences the provision of maternal nutrients via the placental production of hormones that regulate maternal metabolism. The placenta is the site of exchange between mother and fetus and regulates fetal growth via the production and metabolism of growth-regulating hormones such as IGFs and glucocorticoids. Adequate trophoblast invasion in early pregnancy and increased uteroplacental blood flow ensure sufficient growth of the uterus, placenta, and fetus. The placenta may respond to fetal endocrine signals to increase transport of maternal nutrients by growth of the placenta, by activation of transport systems, and by production of placental hormones to influence maternal physiology and even behavior. There are consequences of poor fetal growth both in the short term and long term, in the form of increased mortality and morbidity. Endocrine regulation of fetal growth involves interactions between the mother, placenta, and fetus, and these effects may program long-term physiology.

This article has been cited by other articles:

				A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, June 13, 2008; (2008) dmn021v1. [Abstract] [Full Text] [PDF]

				T. D. Scholz and J. L. Segar Cardiac Metabolism in the Fetus and Newborn NeoReviews, March 1, 2008; 9(3): e109 - e118. [Abstract] [Full Text] [PDF]

				C. Chiesa, J. F. Osborn, C. Haass, F. Natale, M. Spinelli, E. Scapillati, A. Spinelli, and L. Pacifico Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry? Clin. Chem., March 1, 2008; 54(3): 550 - 558. [Abstract] [Full Text] [PDF]

				D. C. Coutinho, R. R. D. Coletta, E. M. F. Costa, P. R. Pachi, M. C. S. Boguszewski, D. Damiani, B. B. Mendonca, I. J. P. Arnhold, and A. A. L. Jorge Polymorphisms Identified in the Upstream Core Polyadenylation Signal of IGF1 Gene Exon 6 Do Not Cause Pre- and Postnatal Growth Impairment J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4889 - 4892. [Abstract] [Full Text] [PDF]

				I. Netchine, S. Rossignol, M.-N. Dufourg, S. Azzi, A. Rousseau, L. Perin, M. Houang, V. Steunou, B. Esteva, N. Thibaud, et al. 11p15 Imprinting Center Region 1 Loss of Methylation Is a Common and Specific Cause of Typical Russell-Silver Syndrome: Clinical Scoring System and Epigenetic-Phenotypic Correlations J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3148 - 3154. [Abstract] [Full Text] [PDF]

				E. Milne, C. L. Laurvick, E. Blair, C. Bower, and N. de Klerk Fetal Growth and Acute Childhood Leukemia: Looking Beyond Birth Weight Am. J. Epidemiol., July 15, 2007; 166(2): 151 - 159. [Abstract] [Full Text] [PDF]

				N. Karlberg, H. Jalanko, and M. Lipsanen-Nyman Growth and Growth Hormone Therapy in Subjects With Mulibrey Nanism Pediatrics, July 1, 2007; 120(1): e102 - e111. [Abstract] [Full Text] [PDF]

				L. J. JARA, H. PACHECO-REYES, G. MEDINA, U. ANGELES, P. CRUZ-CRUZ, and M. A. SAAVEDRA Prolactin Levels Are Associated with Lupus Activity, Lupus Anticoagulant, and Poor Outcome in Pregnancy Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 218 - 226. [Abstract] [Full Text] [PDF]

				P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter Small for Gestational Age: Short Stature and Beyond Endocr. Rev., April 1, 2007; 28(2): 219 - 251. [Abstract] [Full Text] [PDF]

				S. M. McGillivray, V. G. Thackray, D. Coss, and P. L. Mellon Activin and Glucocorticoids Synergistically Activate Follicle-Stimulating Hormone {beta}-Subunit Gene Expression in the Immortalized L{beta}T2 Gonadotrope Cell Line Endocrinology, February 1, 2007; 148(2): 762 - 773. [Abstract] [Full Text] [PDF]

				G. Wu, F. W. Bazer, J. M. Wallace, and T. E. Spencer BOARD-INVITED REVIEW: Intrauterine growth retardation: Implications for the animal sciences J Anim Sci, September 1, 2006; 84(9): 2316 - 2337. [Abstract] [Full Text] [PDF]